article · International Journal of Pharmaceutics

Development of arsenic nanoparticles: a novel topical therapy for psoriasis enhancing skin deposition and preventing relapse for long-term efficacy in imiquimod-induced rat model

2025Pharos University in Alexandria

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Retinoids in leukemia and cellular processes
Psoriasis: Treatment and Pathogenesis
Research on Leishmaniasis Studies

Sustainable Development Goals

Zero Hunger

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.ijpharm.2025.126020

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.